Shruthi Naik

Also affiliated with University of Minnesota Rochester, Mayo Clinic in Arizona

Biochemistry, Genetics and Molecular BiologyAgricultural and Biological SciencesEngineeringMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Development and validation of IMMUNO-COV™: a high-throughput clinical assay for detecting antibodies that neutralize SARS-CoV-2”.

Development and validation of IMMUNO-COV™: a high-throughput clinical assay for detecting antibodies that neutralize SARS-CoV-2

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.05.26.117549

N/A

0DataRank · unranked

19 citations

Timothy S. Carey, Samantha Reiter, Patrycja Lech, Clement W. Gnanadurai, Mulu Z. Tesfay +22 more

Safety and efficacy of neoadjuvant intravesical oncolytic MV-NIS in patients undergoing radical cystectomy (RC) for urothelial carcinoma but ineligible for neoadjuvant cisplatin-based chemotherapy.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps3172

N/A

0DataRank · unranked

1 citations

Tanner Miest, Paul R. Young, Mark L. Gonzalgo, Stephen A. Boorjian, Matthew K. Tollefson +15 more

IMMUNO-COV v2.0: Development and Validation of a High-Throughput Clinical Assay for Measuring SARS-CoV-2-Neutralizing Antibody Titers

mSphere(2021)10.1128/msphere.00170-21

N/A

0DataRank · unranked

32 citations

Timothy S. Carey, Samantha Reiter, Chase Lathrum, Patrycja Lech, Clement W. Gnanadurai +18 more

IMMUNO-COV™ v2.0: Development and Validation of a High-Throughput Clinical Assay for Measuring SARS-CoV-2-Neutralizing Antibody Titers

medRxiv(2021)10.1101/2021.02.16.21251653

N/A

0DataRank · unranked

1 citations

Timothy S. Carey, Samantha Reiter, Chase Lathrum, Patrycja Lech, Clement W. Gnanadurai +18 more

Safety and efficacy of neoadjuvant intravesical oncolytic MV-NIS in patients with urothelial carcinoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.509

N/A

0DataRank · unranked

8 citations

Bradley C. Leibovich, Tanner Miest, Stephen Bardot, Paul R. Young, Stephen A. Boorjian +14 more

Neoadjuvant systemic oncolytic vesicular stomatitis virus is safe and may enhance long-term survivorship in dogs with naturally occurring osteosarcoma

Molecular Therapy — Oncolytics(2023)10.1016/j.omto.2023.100736

N/A

0DataRank · unranked

23 citations

Aaron L. Sarver, Michael S. Henson, Kathleen Stuebner, Antonella Borgatti, Lukkana Suksanpaisan +19 more

Phase 1/2 trial of vesicular stomatitis virus expressing human interferon-β and NIS (VSV-IFNβ-NIS), with pembrolizumab, in patients with neuroendocrine carcinoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps657

N/A

0DataRank · unranked

6 citations

Shruthi Naik, Þorvarður R. Hálfdánarson, Konstantinos Leventakos, Kah Whye Peng, Stephen J. Russell +3 more

Extended Survival in a Dog with Primary Bone Hemangiosarcoma Following Treatment with Neoadjuvant Oncolytic Virotherapy and Standard of Care

Veterinary Sciences(2025)10.3390/vetsci12100921

N/A

0DataRank · unranked

0 citations

Andrea Chehadeh, Amber L. Winter, Sara Pracht, Kathy Stuebner, Mitzi Lewellen +11 more